To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
15 Current news of Evotecrss
Evotec OAI, a partner for integrated high-value-added drug discovery to the pharmaceutical and biotechnology industries, announced today the successful completion of its assay development programme with ALTANA Pharma AG. In close collaboration with scientists at ALTANA Pharma Evotec OAI has ...
Evotec OAI AG, Hamburg, Germany (Neuer Markt: EVT), a supplier of integrated high-value-added drug discovery services, announced today that it has entered into an agreement with Merck & Co., Inc. to synthesise small molecule chemical libraries. This represents a most significant collaboration ...
Evotec OAI AG, Hamburg, Germany, a supplier of integrated high-value added drug discovery services, announced today a contract agreement with Byk Gulden Lomberg Chemische Fabrik GmbH, Altana AG’s pharmaceutical group, Konstanz, Germany. In close collaboration with Byk Gulden, Evotec OAI will ...
Evotec OAI, Hamburg, Germany (EVOTEC BioSystems AG, Neuer Markt: EVT), a supplier of integrated high-value added biological, chemical and screening services, and MelTec GmbH, a pioneer in topological proteomics, announced today that they have entered into a collaboration. The agreement ...
Evotec OAI, Hamburg, Germany (EVOTEC BioSystems AG, Neuer Markt: EVT) a supplier of high value added biological, chemical and screening services, has signed a one-year contract to supply chemical compound libraries and associated data to Roche, of Basel, Switzerland. The compounds will be ...